Skip to main content
MedMen Enterprises Inc. logo

MedMen Enterprises Inc. — Investor Relations & Filings

Ticker · MMNFQ ISIN · CA58507M1077 LEI · 254900FFBPONQV04RD14 CSE Wholesale and retail trade
Open in API
Filings indexed 518 across all filing types
Latest filing 2020-07-03 Capital/Financing Update
Country CA Canada
Listing CSE MMNFQ

About MedMen Enterprises Inc.

https://medmen.com/

MedMen Enterprises Inc. is a cannabis retailer that historically operated dispensaries and cultivation facilities across key U.S. markets, including California, Nevada, Illinois, Massachusetts, and New York. The company focused on delivering a modern, high-end retail experience, offering a curated selection of cannabis products such as flower, pre-rolls, vapes, edibles, concentrates, and CBD wellness items. Its business model emphasized transparency, knowledgeable staff, and seamless online ordering with in-store pickup. As of May 2024, MedMen Enterprises Inc. has filed for bankruptcy and initiated receivership proceedings in California.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding amendments and agreements with lenders and landlords as part of a financial restructuring and turnaround plan. It discusses modifications to loan agreements, interest deferrals, lease arrangements, issuance of warrants, and related party transactions. The content focuses on financing activities, capital structure changes, and debt covenant amendments. There are no financial statements or comprehensive financial performance data presented, nor is this a transcript, management report, or regulatory filing of a different nature. The document is not a brief announcement of voting results or a report publication notice. Given the detailed nature of financing and capital structure updates, this fits best under the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2020-07-03 English
Material change report - English.pdf
Board/Management Information Classification · 100% confidence The document is a FORM 51-102F3 Material Change Report, which is a regulatory filing used to disclose significant changes in a company. The content specifically announces that Adam Bierman stepped down from the Board of Directors. This is an announcement of a change in the company's board, which fits the category of Board/Management Information (MANG). The document is short and focused on this management change, not a full annual report or audit report. Therefore, the correct classification is MANG.
2020-06-24 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document announces changes to the company's Board of Directors, specifically the stepping down of two co-founders from board roles. It also discusses the resolution of litigation involving the company. There is no detailed financial data, no mention of a report being attached or published, and the document is primarily an announcement of management/board changes and legal settlement. Therefore, it fits best under Board/Management Information (MANG). The document length is 4011 characters, which is relatively short and consistent with an announcement rather than a full report.
2020-06-17 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed press release reporting MedMen's third quarter fiscal 2020 financial results, including revenue, EBITDA, cash flow, balance sheet, and capital market activities. It includes management commentary, operational highlights, governance updates including board changes, and mentions a conference call for further discussion. The document contains substantive financial data and analysis for a fiscal quarter, not just a brief earnings highlight or announcement. It also references the availability of the Interim Financial Statements and MD&A on SEDAR, indicating this document is a comprehensive quarterly financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2020
2020-05-27 English
News release - English.pdf
Regulatory Filings
2020-05-27 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2, which is a Certification of Interim Filings for a Venture Issuer. It is signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended March 28, 2020. The document does not contain actual financial data or substantive financial analysis but is a certification letter regarding the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3064 characters), and it is clearly a certification rather than the report itself.
2020-05-27 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.